Two COVID-19 Vaccine Scientists Win 2021 Lasker Award in Medicine

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Katalin Kariko, PhD, a senior vice president at BioNTech, and Drew Weissman, MD, PhD, a professor in vaccine research at the University of Pennsylvania, Philadelphia, Pennsylvania, made a breakthrough discovery by modifying messenger RNA (mRNA), which provides instructions to cells to make proteins.

Dr Katalin Kariko

They found that adding modified mRNA to cells could briefly prompt cells to make any protein they chose. This tool enabled the quick development of COVID-19 vaccines — and is already fueling the development of treatments for a range of other illnesses, including cancers, infectious diseases, and autoimmune disorders.

The Lasker Awards are among the most prestigious prizes in medicine. Winners often go on to receive the Nobel Prize and other major awards.

When Kariko and Weissman discovered the technology in 2005, they received little attention. They wrote grants to continue their work on mRNA modification, but the applications were rejected.

Dr Drew Weissman

In recent years, Moderna and BioNTech took notice and used the technology to develop mRNA vaccines for the flu and other illnesses, though they didn’t move out of clinical trials for years.

Then the coronavirus pandemic began. Moderna and Pfizer-BioNTech decided to use the mRNA modification to make COVID-19 vaccines.

Now Kariko and Weissman are being recognized with numerous awards, including the $3 million Breakthrough Prize and the $1 million Albany Prize. The Lasker Prize carries an honorarium of $250,000.

“Together with my colleagues we inched towards a solution, building upon discoveries of scientists who came before us, and created the optimal RNA suitable for therapy,” Kariko said in accepting the award. “Never in a million years would I have imagined that it would be used to create a vaccine to combat a global pandemic.”

Weissman applauded the years of work that led up to the mRNA vaccines.

“Although the investigations that we began over two decades ago have culminated in significant discoveries and a vaccine against a pandemic-causing virus, the work continues,” he said in his acceptance speech. “I’m thrilled to say that my lab is pursuing new mRNA vaccines to guard against a host of infectious diseases, like influenza and HIV, and even a pan-coronavirus vaccine that could offer protection against all viruses in the coronavirus category.”

For more news, follow Medscape on Facebook, Twitter, Instagram, and YouTube.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Leading Causes of Death Hit Childhood Cancer Survivors Earlier thumbnail

Leading Causes of Death Hit Childhood Cancer Survivors Earlier

Oncology/Hematology > Other Cancers — But excess risk lowest in survivors with a healthy lifestyle by Mike Bassett, Staff Writer, MedPage Today April 6, 2023 Survivors of childhood cancer had a fourfold higher risk of mortality decades after their diagnosis, typically from the same leading causes of death afflicting the general U.S. population, a report
Read More
Ortopedi Ameliyatı Sonrası Fizik Tedavi Şart! thumbnail

Ortopedi Ameliyatı Sonrası Fizik Tedavi Şart!

Ortopedik ameliyatlar sonrasındaki rehabilitasyonlar, kişinin günlük yaşamdaki aktivitelerine bağımsız olarak dönmelerinde önemli rol oynar. Bu yüzden ameliyat sonrası süreçte fizik tedavi çok önemlidir. Hatta ameliyat öncesi başlanan rehabilitasyon ile kasları olabildiğince güçlendirerek, sonraki süreci de kolaylaştırmaktadır.Dr. Hasan MolaaliFizik Tedavi ve Rehabilitasyon UzmanıVücuttaki kemik, kas, sinirlerle ilgili operasyonlar ortopedi ve travmatoloji, ameliyat sonrası süreçte fizik tedavi…
Read More
Side Benefit of Botulinum Toxin A? Reduced IOP in Hemifacial Spasm thumbnail

Side Benefit of Botulinum Toxin A? Reduced IOP in Hemifacial Spasm

Ophthalmology > Glaucoma — Patients with hemifacial spasm and glaucoma need eye follow-up after injection by Diana Swift, Contributing Writer, MedPage Today October 29, 2023 Injection with botulinum toxin A (BTX-A) for hemifacial spasm (HFS) may have an additional benefit: decreasing unilateral eyelid spasms and intraocular pressure (IOP), according to a small Brazilian study. Mean
Read More
Report finds food testing policies different between countries thumbnail

Report finds food testing policies different between countries

There are various approaches to food sampling in four nations, including the United States, as shown in a report published by the Food Standards Agency (FSA). Campden BRI reviewed food control systems in Australia, Canada, New Zealand, and the United States. The study looked at how authorities perform sampling and analysis of food and feed,…
Read More
Index Of News